Annual report 2023*

13 Property, plant and equipment

 

 

2023

millions of CHF

 

Land and buildings

 

Machinery and technical equipment

 

Other non-current assets

 

Tangible assets under construction

 

Total

Acquisition cost

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

68.0

 

203.6

 

17.7

 

31.0

 

320.3

Acquired through business combination

 

2.6

 

2.4

 

0.1

 

 

5.1

Additions

 

0.8

 

23.1

 

1.5

 

34.7

 

60.1

Disposals

 

–0.5

 

–8.7

 

–0.4

 

 

–9.5

Reclassifications

 

1.4

 

16.4

 

0.7

 

–23.9

 

–5.5

Currency translation differences

 

–2.6

 

–7.6

 

–0.7

 

–2.0

 

–13.0

Balance as of December 31

 

69.8

 

229.1

 

18.9

 

39.8

 

357.6

 

 

 

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

26.7

 

126.6

 

9.3

 

 

162.7

Additions

 

3.3

 

17.7

 

1.9

 

 

22.8

Disposals

 

–0.4

 

–8.5

 

–0.4

 

 

–9.3

Impairments

 

 

2.4

 

 

 

2.4

Currency translation differences

 

–0.6

 

–4.3

 

–0.4

 

 

–5.3

Balance as of December 31

 

29.0

 

133.9

 

10.5

 

 

173.4

 

 

 

 

 

 

 

 

 

 

 

Net book value

 

 

 

 

 

 

 

 

 

 

As of January 1

 

41.3

 

76.9

 

8.4

 

31.0

 

157.6

As of December 31

 

40.8

 

95.2

 

8.4

 

39.8

 

184.2

 

 

2022

millions of CHF

 

Land and buildings

 

Machinery and technical equipment

 

Other non-current assets

 

Tangible assets under construction

 

Total

Acquisition cost

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

68.9

 

218.6

 

17.1

 

22.6

 

327.1

Acquired through business combination

 

 

0.9

 

 

 

0.9

Deconsolidation of medmix Poland

 

–0.3

 

–22.9

 

–0.4

 

–1.8

 

–25.3

Additions

 

0.3

 

7.3

 

1.3

 

27.5

 

36.4

Disposals

 

–1.0

 

–7.1

 

–1.2

 

 

–9.3

Reclassifications

 

2.3

 

12.9

 

1.5

 

–16.8

 

Currency translation differences

 

–2.2

 

–6.2

 

–0.6

 

–0.5

 

–9.5

Balance as of December 31

 

68.0

 

203.6

 

17.7

 

31.0

 

320.3

 

 

 

 

 

 

 

 

 

 

 

Accumulated depreciation

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

24.6

 

131.4

 

7.1

 

0.6

 

163.7

Deconsolidation of medmix Poland

 

–0.1

 

–12.2

 

1.9

 

 

–10.4

Additions

 

3.0

 

15.7

 

1.6

 

 

20.3

Disposals

 

–0.5

 

–6.0

 

–1.0

 

–0.6

 

–8.0

Impairments

 

 

1.5

 

0.0

 

 

1.5

Currency translation differences

 

–0.3

 

–3.8

 

–0.2

 

 

–4.4

Balance as of December 31

 

26.7

 

126.6

 

9.3

 

 

162.7

 

 

 

 

 

 

 

 

 

 

 

Net book value

 

 

 

 

 

 

 

 

 

 

As of January 1

 

44.2

 

87.1

 

9.9

 

22.0

 

163.3

As of December 31

 

41.3

 

76.9

 

8.4

 

31.0

 

157.6

The group performed impairment tests on production machines and facilities, resulting in impairments of CHF 2.4 million as of December 31, 2023 (December 31, 2022: CHF 1.5 million), all of which were charged to other operating expenses.

In 2023, the group sold property, plant and equipment with a net book value of CHF 0.2 million for CHF 0.2 million, resulting in a net gain of CHF 0.0 million (2022: property, plant and equipment with a net book value of CHF 1.3 million sold for CHF 1.3 million, resulting in a net gain of CHF 0.0 million).